PneumoBlast

N/A

Report date: 2025/01/26 15:33:59

Base Information

Drug NamePneumoBlast
Drug Alias Namefibroblast cell therapy (FibroGenesis)fibroblast cell therapy (FibroGenesis)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Blood Coagulation DisordersRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFibroGenesis
China Registration ClassN/A

Develop Information

Active CompaniesFibroGenesis
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Blood Coagulation DisordersRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A